NCT00887718
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +9 more
- Locations
-
- University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,966 public trials
2,023 recruiting studies
Immunoproliferative Disorders trial results
NCT00186303
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
NCT00031655
- Conditions
- Adult Acute Lymphoblastic Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Hematologic Diseases, +12 more
- Locations
-
- Oregon Health and Sciences University Portland, Oregon, United States
- Veterans Affairs Puget Sound Healthcare System Seattle, Washington, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma
NCT00634452
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphomas, +7 more
- Locations
-
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- ClinWorks Cancer Research Center Charlotte, North Carolina, United States
Completed
Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients
NCT00323557
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Chronic Disease, +25 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00002687
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- University of Washington Medical Center Seattle, Washington, United States
NCT00920842
- Conditions
- Bone Marrow Diseases, Cardiovascular Complications, Chronic Disease, +25 more
- Locations
-
- Clinical Research Center - Seattle Children's Hospital Seattle, Washington, United States
NCT00412997
- Conditions
- Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Novartis Investigative Site Tokyo, Japan
Completed
Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma
NCT00882063
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Jaslok Hospital & Research Centre Mumbai, Maharashtra, India
- Shatabdi Superspeciality Hospital Nashik, Maharashtra, India
- Rajiv Gandhi Cancer Institute And Research Centre Delhi, National Capital Territory of Delhi, India
- Institute Rotary Cancer Hospital,All India Institute Of Medical Sciences(AIIMS) New Delhi, India
Completed
HYPONCO - Hypoxia in Brain Tumors
NCT01200134
- Conditions
- Anaplastic Glioma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Caen University Hospital Caen, France